Accepted: 17 March 2021
First Online: 19 April 2021
: P.C.T. has received research grants, consultation fees and/or speaking fees from AbbVie, Biogen, Bristol-Myers Squibb, Celgene, Celltrion, Fresenius, Galapagos, Gilead, GlaxoSmithKline, Janssen, Eli Lilly and Company, Sanofi, Nordic Pharma, Pfizer, Roche and UCB. A.C.A., I.d.l.T. and M.M.H. are employees and shareholders of Eli Lilly and Company. K.W. has received research grants from Bristol-Myers Squibb and Pfizer and consulting fees from AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Company, Galapagos, GlaxoSmithKline, Gilead, Novartis, Pfizer, Regeneron, Roche, Sanofi and UCB. R.L.G. reports non-financial support from Gilead Sciences Inc. and personal fees from Gilead Sciences Inc. outside the submitted work.
Free to read: This content has been made available to all.